Cumberland Pharmaceuticals INC (CPIX) — 8-K Filings

All 8-K filings from Cumberland Pharmaceuticals INC. Browse 23 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (23)

8-K Filing — Apr 24, 2026
8-K Filing — Apr 23, 2026
Cumberland Pharmaceuticals Enters Material Definitive Agreement — Nov 24, 2025 Risk: medium
On November 18, 2025, Cumberland Pharmaceuticals Inc. entered into a material definitive agreement, creating a direct financial obligation. The specific details
Cumberland Pharmaceuticals Files 8-K on Financials — Nov 4, 2025 Risk: low
Cumberland Pharmaceuticals Inc. filed an 8-K on November 4, 2025, reporting on its results of operations and financial condition. The filing includes financial
Cumberland Pharmaceuticals Files 8-K: Other Events — Oct 21, 2025 Risk: medium
On October 21, 2025, Cumberland Pharmaceuticals Inc. filed a Form 8-K to report "Other Events." The filing does not contain specific details about the nature of
Cumberland Pharmaceuticals Files 8-K on Financials — Aug 5, 2025 Risk: low
Cumberland Pharmaceuticals Inc. filed an 8-K on August 5, 2025, reporting on its results of operations and financial condition, as well as financial statements
Cumberland Pharmaceuticals Files 8-K — May 6, 2025 Risk: low
Cumberland Pharmaceuticals Inc. filed an 8-K on May 6, 2025, reporting on its results of operations and financial condition, as well as financial statements and
Cumberland Pharmaceuticals Files 8-K on Shareholder Votes — Apr 28, 2025 Risk: low
Cumberland Pharmaceuticals Inc. filed an 8-K on April 28, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain sp
Cumberland Pharmaceuticals Files 8-K Report — Mar 19, 2025 Risk: low
On March 19, 2025, Cumberland Pharmaceuticals Inc. filed an 8-K report. The filing indicates that the company is located at 1600 West End Avenue, Suite 1300, Na
Cumberland Pharmaceuticals Files 8-K — Mar 4, 2025 Risk: low
Cumberland Pharmaceuticals Inc. filed an 8-K on March 4, 2025, reporting on its results of operations and financial condition. The filing includes financial sta
Cumberland Pharmaceuticals Files 8-K Report — Feb 19, 2025 Risk: low
On February 19, 2025, Cumberland Pharmaceuticals Inc. filed an 8-K report. The filing primarily concerns "Other Events" and does not detail specific transaction
Cumberland Pharmaceuticals Files 8-K — Feb 14, 2025 Risk: low
Cumberland Pharmaceuticals Inc. filed an 8-K on February 14, 2025, reporting other events and financial statements. The filing does not contain specific financi
Cumberland Pharmaceuticals Files 8-K Report — Feb 4, 2025 Risk: low
On February 4, 2025, Cumberland Pharmaceuticals Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specific fin
Cumberland Pharmaceuticals Files 8-K for Other Events — Dec 9, 2024 Risk: medium
Cumberland Pharmaceuticals Inc. filed an 8-K on December 9, 2024, to report "Other Events." The filing does not contain specific details about the nature of the
Amneal Pharmaceuticals to Acquire Cumberland Pharmaceuticals — Nov 12, 2024 Risk: medium
Cumberland Pharmaceuticals Inc. announced on November 6, 2024, that it has entered into a definitive agreement to be acquired by Amneal Pharmaceuticals LLC. The
Cumberland Pharmaceuticals Files 8-K on Financials — Nov 7, 2024 Risk: low
Cumberland Pharmaceuticals Inc. filed an 8-K on November 7, 2024, to report on its results of operations and financial condition, as well as to file financial s
Amneal Pharmaceuticals to Acquire Cumberland Pharmaceuticals — Nov 6, 2024 Risk: medium
Cumberland Pharmaceuticals Inc. announced on November 6, 2024, that it has entered into a definitive agreement to be acquired by Amneal Pharmaceuticals LLC. The
Cumberland Pharmaceuticals Files 8-K — Nov 4, 2024 Risk: medium
Cumberland Pharmaceuticals Inc. filed an 8-K on November 4, 2024, to report other events. The filing does not contain specific details about the nature of these
Cumberland Pharmaceuticals Files 8-K on Financials — Aug 6, 2024 Risk: low
Cumberland Pharmaceuticals Inc. filed an 8-K on August 6, 2024, to report on its financial condition and results of operations. The filing includes financial st
Cumberland Pharmaceuticals Files 8-K on Financials — May 7, 2024 Risk: low
Cumberland Pharmaceuticals Inc. filed an 8-K on May 7, 2024, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and
Cumberland Pharmaceuticals Files 8-K on Shareholder Vote Matters — Apr 29, 2024 Risk: low
Cumberland Pharmaceuticals Inc. filed an 8-K on April 29, 2024, to report on a submission of matters to a vote of security holders. The filing does not contain
Cumberland Pharmaceuticals Files 8-K — Mar 20, 2024 Risk: low
Cumberland Pharmaceuticals Inc. filed an 8-K on March 20, 2024, to report other events and file financial statements and exhibits. The filing does not contain s
Cumberland Pharmaceuticals Files 8-K — Mar 5, 2024 Risk: low
Cumberland Pharmaceuticals Inc. filed an 8-K on March 5, 2024, to report on its results of operations and financial condition, as well as to file financial stat

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX